Cardinal Health Raises FY24 Non-GAAP EPS Guidance; Sees Pharmaceutical Revenue Growth Of 10%-12%

Cardinal Health (CAH) has raised its fiscal 2024 guidance range for non-GAAP earnings per share to $6.75 to $7.00, from prior guidance range of $6.50 to $6.75. The guidance includes an update to the Pharmaceutical segment profit outlook to 7% to 9% growth, from prior guidance range of 4% to 6% growth. Pharmaceutical segment revenue growth is projected in a range of 10% to 12%.

from RTT - Earnings https://ift.tt/zmijywa
via IFTTT